Sarkaria JN - Search Results

1

Combination of epidermal growth factor receptor targeted therapy with radiation therapy for malignant gliomas.

Krishnan S, Rao RD, James CD, Sarkaria JN. Krishnan S, et al. Among authors: sarkaria jn. Front Biosci. 2003 Jan 1;8:e1-13. doi: 10.2741/895. Front Biosci. 2003. PMID: 12456322 Review.

2

Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy.

Eshleman JS, Carlson BL, Mladek AC, Kastner BD, Shide KL, Sarkaria JN. Eshleman JS, et al. Among authors: sarkaria jn. Cancer Res. 2002 Dec 15;62(24):7291-7. Cancer Res. 2002. PMID: 12499272

3

Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents.

Rao RD, Buckner JC, Sarkaria JN. Rao RD, et al. Among authors: sarkaria jn. Curr Cancer Drug Targets. 2004 Dec;4(8):621-35. doi: 10.2174/1568009043332718. Curr Cancer Drug Targets. 2004. PMID: 15578919 Review.

4

Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.

Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, Carlson BL, Schroeder MA, James CD. Giannini C, et al. Among authors: sarkaria jn. Neuro Oncol. 2005 Apr;7(2):164-76. doi: 10.1215/S1152851704000821. Neuro Oncol. 2005. PMID: 15831234 Free PMC article.

5

Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells.

Rao RD, Mladek AC, Lamont JD, Goble JM, Erlichman C, James CD, Sarkaria JN. Rao RD, et al. Among authors: sarkaria jn. Neoplasia. 2005 Oct;7(10):921-9. doi: 10.1593/neo.05361. Neoplasia. 2005. PMID: 16242075 Free PMC article.

6

Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response.

Sarkaria JN, Carlson BL, Schroeder MA, Grogan P, Brown PD, Giannini C, Ballman KV, Kitange GJ, Guha A, Pandita A, James CD. Sarkaria JN, et al. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2264-71. doi: 10.1158/1078-0432.CCR-05-2510. Clin Cancer Res. 2006. PMID: 16609043

7

Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel.

Sarkaria JN, Yang L, Grogan PT, Kitange GJ, Carlson BL, Schroeder MA, Galanis E, Giannini C, Wu W, Dinca EB, James CD. Sarkaria JN, et al. Mol Cancer Ther. 2007 Mar;6(3):1167-74. doi: 10.1158/1535-7163.MCT-06-0691. Mol Cancer Ther. 2007. PMID: 17363510

8

Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy.

Dinca EB, Sarkaria JN, Schroeder MA, Carlson BL, Voicu R, Gupta N, Berger MS, James CD. Dinca EB, et al. Among authors: sarkaria jn. J Neurosurg. 2007 Sep;107(3):610-6. doi: 10.3171/JNS-07/09/0610. J Neurosurg. 2007. PMID: 17886562

9

Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.

Liu C, Sarkaria JN, Petell CA, Paraskevakou G, Zollman PJ, Schroeder M, Carlson B, Decker PA, Wu W, James CD, Russell SJ, Galanis E. Liu C, et al. Among authors: sarkaria jn. Clin Cancer Res. 2007 Dec 1;13(23):7155-65. doi: 10.1158/1078-0432.CCR-07-1306. Clin Cancer Res. 2007. PMID: 18056196

10

Mechanisms of chemoresistance to alkylating agents in malignant glioma.

Sarkaria JN, Kitange GJ, James CD, Plummer R, Calvert H, Weller M, Wick W. Sarkaria JN, et al. Clin Cancer Res. 2008 May 15;14(10):2900-8. doi: 10.1158/1078-0432.CCR-07-1719. Clin Cancer Res. 2008. PMID: 18483356 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters